Drug Firms Avert Landmark Opioid Trial As Talks On $48-billion Settlement Set To Resume

Reuters: U.S., Reuters: Nation
Mon, 10/21/2019 - 4:45pm

Four large drug companies could resume talks on Tuesday to try to reach a $48 billion settlement of all opioid litigation against them, after agreeing with two Ohio counties to a $260 million deal to avert the first federal trial over their role in the U.S. opioid epidemic.

1
2

Topics: ohio u.s drug avert opioid trial talks settlement set resume

1
2